Mayfair Advisory Group’s Qiagen QGEN Stock Holding History

Mayfair Advisory Group’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,180	Closed	-$268K	–	164
2024 Q2	$268K	Buy	+6,180	New	+$271K	0.18%	110

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Mayfair Advisory Group's QGEN Position: Q3 2024 in Review

Mayfair Advisory Group sold out of Qiagen (QGEN) in Q3 2024, closing a stake of 6,180 shares — an estimated $268K sold.

Mayfair Advisory Group first reported a position in QGEN in Q2 2024 and held it in 1 quarter. The position peaked at $268K in Q2 2024. 329 funds tracked by Wall St. Rank hold QGEN as of Q3 2024.

Mayfair Advisory Group reported no remaining Qiagen position as of Q3 2024 after selling out during the quarter.
Mayfair Advisory Group sold 6,180 Qiagen shares in Q3 2024, an estimated $268K.
Mayfair Advisory Group first reported a position in Qiagen in Q2 2024 and held it in 1 quarter.
Mayfair Advisory Group's Qiagen position peaked at $268K in Q2 2024.
329 funds tracked by Wall St. Rank held Qiagen as of Q3 2024.

Based on Mayfair Advisory Group's 13F filing for Q3 2024, filed 23 Oct 2024.